Brian McCollum becomes Orthofix's CFO
This article was originally published in Clinica
Orthopaedic specialist Orthofix International has promoted Brian McCollum to the post of chief financial officer. Mr McCollum has worked for the company for almost 10 years, and has been serving as interim CFO since January. Before joining Lewisville, Texas-based Orthofix, Mr McCollum was a senior audit associate with PriceWaterhouseCoopers. Last month, Orthofix reported a 3% increase in revenues for 2010, to $564.4m. Full-year net income was also up 31% to $39m. In December, the company announced it had reduced its workforce in its global spine, orthopaedics and sports medicine businesses as part of a plan to improve its profit margin (www.clinica.co.uk, 16 December 2010).
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.